Corrigendum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease

The following changes have been made to the originally published version of this manuscript: A passage under the title “Indications for intervention” should read, “women with low BSA, TGFBR2 mutation, and severe extra-aortic features”, instead of “women with low BSA, patients with a TGFBR2 mutation, or patients with severe extra-aortic features that appear to be at particularly high risk”. Note ‘e’ from the legend for the table titled Recommendations on indications for surgery in (A) severe aortic regurgitation and (B) aortic root or tubular ascending aortic aneurysm (irrespective of the severity of aortic regurgitation) should read, “A lower threshold of 40 mm may be considered in women with low BSA” instead of “A lower threshold of 40 mm may be considered in women with low BSA, in patients with a TGFBR2 mutation or in patients with severe extra-aortic features”.